Pathological examination of liver and kidney after SCF+G-CSF treatment during chronic stroke in aged SHRs. Livers and kidneys were taken 14 weeks after the SCF+G-CSF treatment. (A &B) Liver and kidney weight. Noting that there are no differences among the groups, indicating that the treatment has no toxic effects on the liver and kidney. (C-F) hematoxylin and eosin staining in liver and kidney sections. Noting that no damage is seen in both liver and kidney after SCF+G-CSF treatment. Arrows in C &D: the bile canaliculus. Arrows in E &F: renal tubules. N= 3–8. Mean ± SE.